These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34725784)

  • 1. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
    Nishioka Y; Paez-Arango N; Boettcher FO; Kawaguchi Y; Newhook TE; Chun YS; Tzeng CD; Tran Cao HS; Lee JE; Vreeland TJ; Vauthey JN
    J Gastrointest Surg; 2022 Apr; 26(4):791-801. PubMed ID: 34725784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
    Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
    Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases.
    Nishioka Y; Chun YS; Overman MJ; Cao HST; Tzeng CD; Mason MC; Kopetz SW; Bauer TW; Vauthey JN; Newhook TE;
    J Am Coll Surg; 2022 Apr; 234(4):474-483. PubMed ID: 35290266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
    Procopio F; Viganò L; Cimino M; Donadon M; Del Fabbro D; Torzilli G
    Eur J Surg Oncol; 2020 May; 46(5):818-824. PubMed ID: 31839435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
    Kawaguchi Y; Lillemoe HA; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Kopetz S; Vauthey JN
    J Am Coll Surg; 2019 Sep; 229(3):286-294.e1. PubMed ID: 31054911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.
    Pawlik TM; Scoggins CR; Zorzi D; Abdalla EK; Andres A; Eng C; Curley SA; Loyer EM; Muratore A; Mentha G; Capussotti L; Vauthey JN
    Ann Surg; 2005 May; 241(5):715-22, discussion 722-4. PubMed ID: 15849507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
    Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases.
    Boyev A; Tzeng CD; Maki H; Arvide EM; Mrema DE; Jain AJ; Haddad A; Lendoire M; Malik N; Odisio BC; Chun YS; Tran Cao HS; Vauthey JN; Newhook TE
    Ann Surg Oncol; 2024 Apr; 31(4):2547-2556. PubMed ID: 38148351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
    Viganò L; Branciforte B; Laurenti V; Costa G; Procopio F; Cimino M; Del Fabbro D; Di Tommaso L; Torzilli G
    Ann Surg Oncol; 2022 Sep; 29(9):5515-5524. PubMed ID: 35687176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
    Viganò L; Costa G; Cimino MM; Procopio F; Donadon M; Del Fabbro D; Belghiti J; Kokudo N; Makuuchi M; Vauthey JN; Torzilli G
    J Gastrointest Surg; 2018 Oct; 22(10):1752-1763. PubMed ID: 29948554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases.
    Kawaguchi Y; Newhook TE; Tran Cao HS; Tzeng CD; Chun YS; Aloia TA; Dasari A; Kopetz S; Vauthey JN
    J Gastrointest Surg; 2021 Jan; 25(1):186-194. PubMed ID: 33205306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
    Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M
    Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival.
    Angelsen JH; Horn A; Eide GE; Viste A
    World J Surg Oncol; 2014 Apr; 12():127. PubMed ID: 24767422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
    Tsilimigras DI; Sahara K; Moris D; Hyer JM; Paredes AZ; Bagante F; Merath K; Farooq AS; Ratti F; Marques HP; Soubrane O; Azoulay D; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Gastrointest Surg; 2020 Jul; 24(7):1552-1560. PubMed ID: 31243714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
    de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
    Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Status of
    Kawaguchi Y; Kopetz S; Newhook TE; De Bellis M; Chun YS; Tzeng CD; Aloia TA; Vauthey JN
    Clin Cancer Res; 2019 Oct; 25(19):5843-5851. PubMed ID: 31221662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.